[Cryopreserved amniotic membranes use in resistant vascular ulcers]

Area of Science:

• Regenerative Medicine
• Wound Healing
• Vascular Surgery

Context:

• Amniotic membranes are successfully used in ophthalmology for corneal conditions.
• Venous and/or arterial vascular ulcers present a significant clinical challenge, often proving resistant to conventional treatments.
• This study investigates a novel application of amniotic membranes for managing refractory vascular ulcers.

Purpose:

• To assess the tolerance of amniotic membranes in patients with resistant venous and/or arterial vascular ulcers.
• To evaluate the efficacy of amniotic membranes in promoting ulcer healing and reducing pain.
• To explore the impact of this treatment on patients' quality of life.

Summary:

• A pilot study involved 8 patients with chronic vascular ulcers treated weekly with amniotic membranes.
• The primary endpoint was tolerance, with secondary endpoints including ulcer area reduction, pain improvement (visual analog scale), and quality of life (SF-36).
• Excellent tolerance was observed in all patients, with no adverse effects. Complete healing occurred in 2 patients, and >50% area reduction in 3 others. Significant pain reduction and improved quality of life were noted.

Impact:

• These preliminary findings suggest amniotic membranes are a safe and potentially effective treatment for resistant vascular ulcers.
• The study highlights the need for larger, confirmatory trials to validate these encouraging results.
• Further research is warranted to elucidate the precise mechanisms of action for amniotic membrane therapy in vascular wound management.